AU2018100842A4 - Pharmaceutical intermediates adipic acid synthesis method - Google Patents

Pharmaceutical intermediates adipic acid synthesis method Download PDF

Info

Publication number
AU2018100842A4
AU2018100842A4 AU2018100842A AU2018100842A AU2018100842A4 AU 2018100842 A4 AU2018100842 A4 AU 2018100842A4 AU 2018100842 A AU2018100842 A AU 2018100842A AU 2018100842 A AU2018100842 A AU 2018100842A AU 2018100842 A4 AU2018100842 A4 AU 2018100842A4
Authority
AU
Australia
Prior art keywords
solution
adipic acid
temperature
added
synthesis method
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2018100842A
Inventor
genan guan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chengdu Qianye Longhua Petroleum Engineering Technology Consulting Co Ltd
Original Assignee
Chengdu Qianye Longhua Petroleum Engineering Technology Consulting Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chengdu Qianye Longhua Petroleum Engineering Technology Consulting Co Ltd filed Critical Chengdu Qianye Longhua Petroleum Engineering Technology Consulting Co Ltd
Application granted granted Critical
Publication of AU2018100842A4 publication Critical patent/AU2018100842A4/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/16Preparation of carboxylic acids or their salts, halides or anhydrides by oxidation
    • C07C51/31Preparation of carboxylic acids or their salts, halides or anhydrides by oxidation of cyclic compounds with ring-splitting

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Pharmaceutical intermediates adipic acid synthesis method Abstract 5 The present invention discloses pharmaceutical intermediates adipic acid synthesis method, comprises the following steps: 2-bromo-cyclohexylamine and potassium sulfate solution is added to the reaction vessel, the stirring speed is controlled, slowly raised the temperature, raised the temperature, continue to react; hexachlorocyclochrome is added in batches, raised the temperature, then the 10 heptanoate solution is added, continued the reaction, sodium nitrate solution is added, reduced the temperature, the solution layer is separated, washed with cyclopentane solution, washed with 3-hexanol solution, recrystallizated in the 3-methyl pyridine solution, dehydrated with dehydration, got the finished adipic acid. 15 Figure 1

Description

The present invention discloses pharmaceutical intermediates adipic acid synthesis method, comprises the following steps: 2-bromo-cyclohexylamine and potassium sulfate solution is added to the reaction vessel, the stirring speed is controlled, slowly raised the temperature, raised the temperature, continue to react; hexachlorocyclochrome is added in batches, raised the temperature, then the heptanoate solution is added, continued the reaction, sodium nitrate solution is added, reduced the temperature, the solution layer is separated, washed with cyclopentane solution, washed with 3-hexanol solution, recrystallizated in the 3-methyl pyridine solution, dehydrated with dehydration, got the finished adipic acid.
Figure 1
2018100842 20 Jun 2018
Pharmaceutical intermediates adipic acid synthesis method
FIELD OF THE INVENTION
The present invention relates to a method for preparing a pharmaceutical 5 intermediate which belongs to the field of organic synthesis, more particularly, relates to pharmaceutical intermediates adipic acid synthesis method.
GENERAL BACKGROLND
Adipic acid is a raw material for pharmaceuticals, yeast purification, insecticides, 10 adhesives, synthesis leathers, synthesis dyes and fragrances. It is also used in the manufacture of plasticizers and lubricants, organic synthesis, fluxes, resins, plastics. It can be used for the production of various ester products, but also for the polyurethane elastomer raw materials. Most of the existing synthesis methods using cyclohexane as raw material, acetic acid as solvent, cobalt and bromide as catalyst, react for 10-13h at the situation of 2MP and 90°C, the final yield of 75%.
This kind of synthesis method requires the use of cobalt and bromide. This compound has high environmental pollution, higher cost of later pollution treatment, higher reaction cost and higher reaction temperature which is above 90 °C, higher energy consumption; longer reaction time, which reached 10-13h, is not conducive to reducing the cost of response, the synthesis method is complicated and the final yield is not very high. Therefore, it is necessary to propose a new synthesis method.
SLMMARY
Based on the technical problems of the background technology, the purpose of the present invention is to provide pharmaceutical intermediates adipic acid synthesis method, comprises the following steps:
A: 2-bromo-cyclohexylamine and potassium sulfate solution is added to the reaction vessel, the stirring speed is controlled at 170-210 rpm, slowly raised the temperature, raised the temperature to 30-40 °C within 80-110 min, continue to react for 50-80 min;
B: hexachlorocyclochrome is added in batches in 1-2 h, raised the temperature to
2018100842 20 Jun 2018
45-52 °C, then the heptanoate solution is added, continued the reaction for 90-130 min, sodium nitrate solution is added, reduced the temperature to 5-9 °C, the solution layer is separated, washed with cyclopentane solution, washed with 3-hexanol solution, recrystallizated in the 3-methyl pyridine solution, dehydrated with dehydration, got the finished adipic acid.
Preferably, the potassium sulfate solution has a mass fraction of 10-16%. Preferably, the mass fraction of the heptanoate solution is 30-37%.
Preferably, the sodium nitrate solution has a mass fraction of 10-15%.
Preferably, the cyclopentane solution has a mass fraction of 40-47%.
Preferably, the mass fraction of 3-hexanol solution is 55-62%.
Preferably, the mass fraction of 3-methyl pyridine solution is 80-86%.
Throughout the reaction process can be the following reaction formula:
NH2
Figure AU2018100842A4_D0001
C8HI6O2 + Cr(CO)6 _J
Figure AU2018100842A4_D0002
COOH
OH2)4
COOH
Compared with the synthesis method disclosed in the background art, the invention provides pharmaceutical intermediates adipic acid synthesis method, it is unnecessary to use cobalt and bromide, avoiding the pollution of this compound on the environment, reducing the cost of post-pollution treatment, and the cost of the reaction, and the reaction temperature is low, it is unnecessary to reach more than 90 °C, which leads to lower energy consumption; reaction time is shortened, and no longer need 10-13h, it is conducive to reducing the cost of response, thus reducing intermediate links reaction, decreasing the reaction time and improving the reaction yield, at the same time, the present invention provides a new synthetic route which has laid a good foundation for further enhancing the yield of the reaction.
DESCRIPTION OF THE DRAWINGS
Figure 1 is the infrared analysis spectrum of finished product adipic acid.
2018100842 20 Jun 2018
DETAILED DESCRIPTION OF PREFERRED EMBODIMENTS
The following examples with reference to specific embodiments of the present invention are further illustrated:
Embodiment 1
Pharmaceutical intermediates adipic acid synthesis method, comprises the following steps:
A: 3mol 2-bromo-cyclohexylamine and 1.3L potassium sulfate solution with a mass fraction of 10% is added to the reaction vessel, the stirring speed is controlled at 170 rpm, slowly raised the temperature, raised the temperature to 30 °C within 80 min, continue to react for 50 min;
B: 3 mol hexachlorocyclochrome is added for 2 times in 1 h, raised the temperature to 45 °C, then 6mol heptanoate solution with a mass fraction of 30% is added, continued the reaction for 90 min, 900ml sodium nitrate solution with a mass fraction of 10% is added, reduced the temperature to 5 °C, the solution layer is separated, washed with cyclopentane solution with a mass fraction of 40%, washed with
3-hexanol solution with a mass fraction of 55%, recrystallizated in the 3-methyl pyridine solution with a mass fraction of 80%, dehydrated with anhydrous magnesium sulfate dehydration, got the finished adipic acid 385.44g, yield of 88%.
Embodiment 2
Pharmaceutical intermediates adipic acid synthesis method, comprises the following steps:
A: 3mol 2-bromo-cyclohexylamine and 1.3L potassium sulfate solution with a mass fraction of 13% is added to the reaction vessel, the stirring speed is controlled at 190 rpm, slowly raised the temperature, raised the temperature to 35 °C within 95 min, continue to react for 65 min;
B: 3.5 mol hexachlorocyclochrome is added for 3 times in 1.5 h, raised the temperature to 48.5 °C, then 7mol heptanoate solution with a mass fraction of 34% is added, continued the reaction for 110 min, 900ml sodium nitrate solution with a mass fraction of 13% is added, reduced the temperature to 7°C, the solution layer is separated, washed with cyclopentane solution with a mass fraction of 44%, washed with
2018100842 20 Jun 2018
3-hexanol solution with a mass fraction of 58%, recrystallizated in the 3-methyl pyridine solution with a mass fraction of 83.5%, dehydrated with anhydrous potassium carbonate dehydration, got the finished adipic acid 402.96g, yield of 92%.
Embodiment 3
Pharmaceutical intermediates adipic acid synthesis method, comprises the following steps:
A: 3mol 2-bromo-cyclohexylamine and 1.3L potassium sulfate solution with a mass fraction of 16% is added to the reaction vessel, the stirring speed is controlled at 210 rpm, slowly raised the temperature, raised the temperature to 40 °C within 110 min, continue to react for 80 min;
B: 4 mol hexachlorocyclochrome is added for 4 times in 2 h, raised the temperature to 52 °C, then 8mol heptanoate solution with a mass fraction of 37% is added, continued the reaction for 130 min, 900ml sodium nitrate solution with a mass fraction of 15% is added, reduced the temperature to 9°C, the solution layer is separated, washed with cyclopentane solution with a mass fraction of 47%, washed with 3-hexanol solution with a mass fraction of 62%, recrystallizated in the 3-methyl pyridine solution with a mass fraction of 86%, dehydrated with anhydrous magnesium sulfate dehydration, got the finished adipic acid 416. lg, yield of 95%.
Infrared analysis of finished product adipic acid, infrared spectrum is shown in figure 1, the analysis of data is shown in table 1.
Table 1 peak data
Serial Peak position Transmittance Half width Peak difference
number (cm'1) (%) (cnf1) (%)
1 678 67 34 24
2 931 48 89 35
3 1188 34 39 43
4 1279 21 57 53
5 1355 61 43 11
The embodiments of the present invention are merely preferred embodiments of the present invention, but the range of the present invention is not limited this, and any person who is familiar with those skilled in the arts, within the technical range of the present invention. It is intended that the technical solution and its inventive concept be replaced or modified equivalently with reference to the range of the invention.
2018100842 20 Jun 2018
2018100842 20 Jun 2018

Claims (4)

  1. Claims
    1. Pharmaceutical intermediates adipic acid synthesis method, comprises the following steps:
    5 A:
  2. 2-bromo-cyclohexylamine and potassium sulfate solution is added to the reaction vessel, the stirring speed is controlled at 170-210 rpm, slowly raised the temperature, raised the temperature to 30-40 °C within 80-110 min, continue to react for 50-80 min;
    B: hexachlorocyclochrome is added in batches in 1-2 h, raised the temperature to 10 45-52 °C, then the heptanoate solution is added, continued the reaction for 90-130 min, sodium nitrate solution is added, reduced the temperature to 5-9 °C, the solution layer is separated, washed with cyclopentane solution, washed with 3-hexanol solution, recrystallizated in the 3-methyl pyridine solution, dehydrated with dehydration, got the finished adipic acid.
    15 2. Pharmaceutical intermediates adipic acid synthesis method according to claim
    1 wherein the potassium sulfate solution has a mass fraction of 10-16%.
  3. 3. Pharmaceutical intermediates adipic acid synthesis method according to claim 1 wherein the mass fraction of the heptanoate solution is 30-37%.
  4. 4. Pharmaceutical intermediates adipic acid synthesis method according to claim
    20 1 wherein the sodium nitrate solution has a mass fraction of 10-15%.
    2018100842 20 Jun 2018
    1/1
    Figure 1
AU2018100842A 2017-08-19 2018-06-20 Pharmaceutical intermediates adipic acid synthesis method Ceased AU2018100842A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201710700038.3A CN108238927A (en) 2017-08-19 2017-08-19 The synthetic method of medicine intermediate adipic acid
CN2017107000383 2017-08-19

Publications (1)

Publication Number Publication Date
AU2018100842A4 true AU2018100842A4 (en) 2018-08-02

Family

ID=60037086

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2018100842A Ceased AU2018100842A4 (en) 2017-08-19 2018-06-20 Pharmaceutical intermediates adipic acid synthesis method

Country Status (3)

Country Link
CN (1) CN108238927A (en)
AU (1) AU2018100842A4 (en)
GB (1) GB201713865D0 (en)

Also Published As

Publication number Publication date
CN108238927A (en) 2018-07-03
GB201713865D0 (en) 2017-10-11

Similar Documents

Publication Publication Date Title
CN107417686B (en) Method for synthesizing avibactam sodium
CA2546683A1 (en) Process for producing dichloropropanol from glycerol, the glycerol coming eventually from the conversion of animal fats in the manufacture of biodiesel
NZ614088A (en) Process for preparing pyridinamines and novel polymorphs thereof
AU2018100842A4 (en) Pharmaceutical intermediates adipic acid synthesis method
CN103724203B (en) The preparation method of o-methyl hydroxyphenylacetate
CN112920050B (en) Synthetic method of methyl fluoroacetate and ethyl fluoroacetate
AU2018100529A4 (en) Vitamin K3 drug intermediates 2- menadione synthesis method
CN107501171B (en) Synthetic method of 2-chloro-3-pyridylaldehyde
CN112851600B (en) Preparation method of high-heat-resistance diepoxide
AU2018100844A4 (en) Chlormadinone drug intermediates o-tetrachlorobenzoquinone synthesis method
CN101880252A (en) Preparation method of valnemulin hydrochloride
CN112250611B (en) Synthesis method of-2- (2, 5-difluorophenyl) pyrrolidine hydrochloride
AU2018100841A4 (en) Organic synthetic intermediate hexanoic acid synthesis method
AU2018100827A4 (en) Drug intermediates 4-benzyloxy-3-methoxy-4'-methylbenzophenone synthesis method
AU2018100822A4 (en) Antitumor drug intermediates 3, 5-tert-butyl-4-hydroxy benzoic acid synthesis method
AU2018100422A4 (en) Drugs intermediates 2-ethylhexanoic acid synthesis method
AU2018100532A4 (en) Anti-arrhythmic drug intermediate 1-(2,6-dimethoxy)-2-acetone synthesis method
AU2018100835A4 (en) Drug intermediates diphenyl acetone synthesis method
CN102267992A (en) Preparation method of pleuromutilin antibiotic
AU2018100824A4 (en) Nitro-cotton intermediates butyl butyrate synthesis method
AU2018100526A4 (en) Drug intermediates p-benzoylbenzoic acid synthesis method
AU2018101117A4 (en) Drug intermediates 3-oxoheptanone ethylene glycol synthesis method
AU2018100831A4 (en) Organic synthesis intermediates 2-tetrolaldehyde synthesis method
AU2018100533A4 (en) 3-trichloroacetyl-2, 2-dimethylcyclopropanecarboxylic acid ethyl ester drug synthesis method
AU2018100365A4 (en) Antagonists medicine intermediates o-nitrobenzoic acid synthesis method

Legal Events

Date Code Title Description
FGI Letters patent sealed or granted (innovation patent)
MK22 Patent ceased section 143a(d), or expired - non payment of renewal fee or expiry